(Q77718601)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9863534%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

review article

1 reference

title

Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9863534%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

J W Heinecke

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9863534%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9863534%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9863534%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9863534%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

1-15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9863534%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9863534%20AND%20SRC:MED&resulttype=core&format=json

A receptor-mediated pathway for cholesterol homeostasis

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Role of oxidized low density lipoprotein in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

The role of oxidized lipoproteins in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Clinical trials of antioxidants in atherosclerosis: are we doing the right thing?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Antioxidants and atherosclerotic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Antioxidant defenses and lipid peroxidation in human blood plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Superoxide initiates oxidation of low density lipoprotein by human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Intact human ceruloplasmin oxidatively modifies low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Identification of the prooxidant site of human ceruloplasmin: a model for oxidative damage by copper bound to protein surfaces

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Autoxidation of lipids and antioxidation by alpha-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Reduction of copper, but not iron, by human low density lipoprotein (LDL). Implications for metal ion-dependent oxidative modification of LDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Alpha-tocopherol as a reductant for Cu(II) in human lipoproteins. Triggering role in the initiation of lipoprotein oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Involvement of preexisting lipid hydroperoxides in Cu(2+)-stimulated oxidation of low-density lipoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Role of lipoprotein-copper complex in copper catalyzed-peroxidation of low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Low density lipoprotein is saturable by pro-oxidant copper.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Factors affecting resistance of low density lipoproteins to oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

The effect of histidine modification on copper-dependent lipid peroxidation in human low-density lipoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Copper ions promote peroxidation of low density lipoprotein lipid by binding to histidine residues of apolipoprotein B100, but they are reduced at other sites on LDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Isoprostanes: potential markers of oxidant stress in atherothrombotic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Hemochromatosis, multiorgan hemosiderosis, and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Are body iron stores related to the risk of coronary heart disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Effect of iron overload and iron deficiency on atherosclerosis in the hypercholesterolemic rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Iron overload augments the development of atherosclerotic lesions in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Mammalian lipoxygenases: molecular structures and functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

5-Lipoxygenase is not essential in macrophage-mediated oxidation of low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Cellular oxidative modification of low density lipoprotein does not require lipoxygenases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblast expressing high levels of human 15-lipoxygenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Fibroblasts that overexpress 15-lipoxygenase generate bioactive and minimally modified LDL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Oxygenation of lipoproteins by mammalian lipoxygenases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

In vivo action of 15-lipoxygenase in early stages of human atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Is NO an endogenous antiatherogenic molecule?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Oxidative chemistry of peroxynitrite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

The participation of nitric oxide in cell free- and its restriction of macrophage-mediated oxidation of low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

A protective role for nitric oxide in the oxidative modification of low density lipoproteins by mouse macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Oxygen Metabolism and the Toxic Properties of Phagocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Leukocytic oxygen activation and microbicidal oxidative toxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Presence of hypochlorite-modified proteins in human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

X-ray crystal structure of canine myeloperoxidase at 3 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Peroxidase-dependent metal-independent oxidation of low density lipoprotein in vitro: a model for in vivo oxidation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Higher oxidation states of prostaglandin H synthase. EPR study of a transient tyrosyl radical in the enzyme during the peroxidase reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Assessment of chlorination by human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Brominating oxidants generated by human eosinophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Human neutrophils employ chlorine gas as an oxidant during phagocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system: potential markers for lipoproteins oxidatively damaged by phagocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Probucol inhibits oxidative modification of low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

The antioxidant butylated hydroxytoluene protects against atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Effect of the antioxidant N,N'-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Atherosclerotic lesion development in hypercholesterolemic Japanese quail following probucol treatment: a biochemical and morphologic evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit — long-term antiatherogenic effect and effects on established plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Vitamin E and fatty acid intervention does not attenuate the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Alpha-tocopherol does not inhibit hypochlorite-induced oxidation of apolipoprotein B-100 of low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein. Use of a new water-soluble probucol derivative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Radical-initiated lipid peroxidation in low density lipoproteins: insights obtained from kinetic modeling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Oxidants as stimulators of signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Paraoxonase-gene polymorphisms associated with coronary heart disease: support for the oxidative damage hypothesis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Plasma high density lipoproteins. Metabolism and relationship to atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Minimally modified low density lipoprotein stimulates monocyte endothelial interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Vitamin E consumption and the risk of coronary disease in women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Vitamin E consumption and the risk of coronary heart disease in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

The composition of coronary-artery plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

7 January 2021

The isoprostanes. Current knowledge and directions for future research

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

7 January 2021

Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

7 January 2021

Probucol pretreatment enhances the chemotaxis of mouse peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900173-7

7 January 2021

10.1016/S0021-9150(98)00173-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9863534%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference